Author

Johan Lindqvist

University of ArizonaORCID 0000-0003-4010-013XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Coen A. C. OttenheijmiD· 1 shared Esmat Karimi· 1 shared Henk L. M. GranzieriD· 1 shared Jochen GohlkeiD· 1 shared Justin S. KolbiD· 1 shared Michael William LawloriD· 1 shared Mila van der Borgh· 1 shared Stacy A. CossetteiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Coen A. C. OttenheijmORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GeneticsbioRxivPreprintDec 20, 2023

Characterization of NEB mutations in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects

Esmat Karimi, Mila van der Borgh, Johan Lindqvist…·Henk L. M. Granzier

This study characterizes NEB mutations in NEM2 patients, revealing mechanisms of nebulin dysfunction and the potential therapeutic benefit of Omecamtiv mecarbil.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky